"10.1371_journal.pone.0055135","plos one","2013-02-01T00:00:00Z","Frank J Calzone; Elaina Cajulis; Young-Ah Chung; Mei- Mei Tsai; Petia Mitchell; John Lu; Ching Chen; Jilin Sun; Robert Radinsky; Richard Kendall; Pedro J Beltran","Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America; Biologic Discovery, Amgen Inc., Thousand Oaks, California, United States of America; Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America; Biologic Optimization, Amgen Inc., Thousand Oaks, California, United States of America; Clinical Immunology, Amgen Inc., Thousand Oaks, California, United States of America","Revised the manuscript critically for important intellectual content: PJB FJC EC YAC MT PM JL CC JS RR RK. Conceived and designed the experiments: FJC PJB RR RK MT CC. Performed the experiments: EC YAC JL PM JS. Analyzed the data: FJC PJB RR JS. Wrote the paper: PJB FJC.","Frank J. Calzone was an employee of Amgen Inc. and owns stock in Amgen Inc. Elaina Cajulis, Young-Ah Chung, Mei- Mei Tsai, Petia Mitchell, John Lu, Ching Chen, Jilin Sun, Robert Radinsky, Richard Kendall, and Pedro J. Beltran are employees of Amgen Inc. and own stock in Amgen Inc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","02","Frank J Calzone","FJC",11,TRUE,6,5,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
